Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant switch study in older adults with insomnia and cognitive frailty
ChiCTR2600133925Phase 4Not yet recruiting
- Sponsor
- Huadong Hospital, Fudan University
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of daridorexant and zolpidem in chronic insomnia (2 arms), sponsored by Huadong Hospital, Fudan University. Primary endpoints: Total Sleep Time at Week 48, Pittsburgh Sleep Quality Index at Week 48 and 2 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
daridorexantzolpidem
03
Conditions
chronic insomnia
Beyond the preview
Go deeper on ChiCTR2600133925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133925.